Details for: INTUNIV XR
Company: TAKEDA CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02409100 | INTUNIV XR | GUANFACINE (GUANFACINE HYDROCHLORIDE) | 1 MG | TABLET (EXTENDED-RELEASE) | ORAL |
| 02409119 | INTUNIV XR | GUANFACINE (GUANFACINE HYDROCHLORIDE) | 2 MG | TABLET (EXTENDED-RELEASE) | ORAL |
| 02409127 | INTUNIV XR | GUANFACINE (GUANFACINE HYDROCHLORIDE) | 3 MG | TABLET (EXTENDED-RELEASE) | ORAL |
| 02409135 | INTUNIV XR | GUANFACINE (GUANFACINE HYDROCHLORIDE) | 4 MG | TABLET (EXTENDED-RELEASE) | ORAL |
Summary Reports
Summary Basis of Decision
Regulatory Decision Summary
Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing the Potential Risk of Raynaud's Phenomenon
Regulatory Decision Summary
Summary Safety Review - INTUNIV XR (guanfacine hydrochloride) - Assessing the Potential Risk of Raynaud's Phenomenon
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.